This study group aimed to revise the 2017 international consensus guidelines for the
management of intraductal papillary mucinous neoplasm (IPMN) of the pancreas, and …

Due to its poor prognosis and the late stage at which it is typically diagnosed, early detection
of pancreatic cancer is a pressing clinical problem. Advances in genomic analysis of human …

Background This systematic review aimed to assess the diagnostic accuracy of the
International Consensus Fukuoka Guidelines (ICG2017) in identifying high-risk lesions of …

Pancreatic cancer is one of the most fatal malignancies, as approximately 80% of patients
are at advanced stages by the time of diagnosis. The main reason for the poor overall …

Pancreatic cancer is a malignant disease characterized by low survival and high recurrence
rate, whose patients are mostly at the stage of locally advanced or metastatic disease when …

ABSTRACT Fibrous dysplasia/McCune‐Albright syndrome (FD/MAS) is a rare mosaic bone
and endocrine disorder. Although most variants affect the GNAS R201 codon, obtaining a …

Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the third leading cause of
cancer-related mortality within the next decade. Management of PDAC remains challenging …

Purpose This study was based on hepatocellular carcinoma (HCC) patients of early-stage to
explore the diagnostic capability and possible production causes of anti-GNAS …

Despite the presence of various guidelines, diagnosing malignant intraductal papillary
mucinous neoplasm (IPMN) continues to pose challenges. Furthermore, although …

Purpose To elucidate the effectiveness of circulating tumor DNA (ctDNA) for predicting occult
metastases in patients with pancreatic cancer without apparent metastases. Methods …